Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2017

17.12.2016 | Original Article

Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China

verfasst von: J. Liu, H. Yang, Z. Yin, X. Jiang, H. Zhong, D. Qiu, F. Zhu, R. Li

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Preeclampsia (PE) is one of the pregnancy metabolic diseases. Since Gut microbiota play important roles in the hosts’ metabolism, it is necessary to investigate the gut microbiota in PE patients, so that some intestinal dysbiosis might be detected as a biomarker for PE early diagnosis or as a target for intervention. One hundred subjects were categorized into four groups: 26 PE patients in late pregnancy, healthy individuals in early, middle, and late pregnancy (26/24/24 women). Gut microbiota were analyzed by sequencing the V4 region of the 16S rDNA gene using Illuminal MiSeq. Data were analyzed by multivariate statistics. Bacteroidetes was the dominant bacterium (47.57–52.35%) in the pregnant women in South China. Tenericutes increased while Verrucomicrobia almost disappeared in late pregnancy. In the PE patients, there was an overall increase in pathogenic bacteria, Clostridium perfringens (p = 0.03) and Bulleidia moorei (p = 0.00) but a reduction in probiotic bacteria Coprococcus catus (p = 0.03). Our research suggests that there is a significant structural shift of the gut microbiota in PE patients, which might be associated with the occurrence and development of the disease. However, further studies are required to understand the underlying mechanisms.
Literatur
1.
Zurück zum Zitat Robergo S, Villa P, Nicolaides K et al (2012) Early administration of low dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta- analysis. Fetal Diagn Ther 31:141–146CrossRef Robergo S, Villa P, Nicolaides K et al (2012) Early administration of low dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta- analysis. Fetal Diagn Ther 31:141–146CrossRef
2.
Zurück zum Zitat Lima VJ, Andrade CR, Ruschi GE et al (2011) Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J 129(2):73–76CrossRefPubMed Lima VJ, Andrade CR, Ruschi GE et al (2011) Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J 129(2):73–76CrossRefPubMed
3.
Zurück zum Zitat Valdés E, Sepúlveda-Martínez A, Manukián B et al (2014) Assessment of pregestational insulin resistance as a risk factor of preeclampsia. Gynecol Obstet Investig 77:111–116CrossRef Valdés E, Sepúlveda-Martínez A, Manukián B et al (2014) Assessment of pregestational insulin resistance as a risk factor of preeclampsia. Gynecol Obstet Investig 77:111–116CrossRef
4.
Zurück zum Zitat Bartha JL, Gonzalez-Bogatto F, Fernandez-Macias R et al (2008) Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 137(2):178–184CrossRefPubMed Bartha JL, Gonzalez-Bogatto F, Fernandez-Macias R et al (2008) Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 137(2):178–184CrossRefPubMed
5.
Zurück zum Zitat Rodie VA, Freeman DJ, Sattar N et al (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175(2):189–202CrossRefPubMed Rodie VA, Freeman DJ, Sattar N et al (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175(2):189–202CrossRefPubMed
6.
Zurück zum Zitat Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11(9):639–647CrossRefPubMed Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11(9):639–647CrossRefPubMed
8.
Zurück zum Zitat Nagata K, Suzuki H, Sakaguchi S et al (2007) Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 32(5):453–468CrossRefPubMed Nagata K, Suzuki H, Sakaguchi S et al (2007) Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 32(5):453–468CrossRefPubMed
9.
Zurück zum Zitat Liévin V, Peiffer I, Hudault S et al (2000) Strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47(5):646–652CrossRefPubMedPubMedCentral Liévin V, Peiffer I, Hudault S et al (2000) Strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47(5):646–652CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Moran C, Sheehan D, Shanahan F (2015) The small bowel microbiota. Curr Opin Gastroenterol 31(2):130–136CrossRefPubMed Moran C, Sheehan D, Shanahan F (2015) The small bowel microbiota. Curr Opin Gastroenterol 31(2):130–136CrossRefPubMed
12.
Zurück zum Zitat Bohr UR, Glasbrenner B, Primus A et al (2004) Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 42(6):2766–2768CrossRefPubMedPubMedCentral Bohr UR, Glasbrenner B, Primus A et al (2004) Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 42(6):2766–2768CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ley RE, Peterson DA, Gordon JI et al (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837–848CrossRefPubMed Ley RE, Peterson DA, Gordon JI et al (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837–848CrossRefPubMed
16.
Zurück zum Zitat Omry K, Julia K, Goodrich et al (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 3:470–480 Omry K, Julia K, Goodrich et al (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 3:470–480
17.
Zurück zum Zitat Van Damme-Jongsten M, Haagsma J, Notermans S (1990) Testing strains of Clostridium perfringens type A isolated from diarrhoeic piglets for the presence of the enterotoxin gene. Vet Rec 126(8):191–192PubMed Van Damme-Jongsten M, Haagsma J, Notermans S (1990) Testing strains of Clostridium perfringens type A isolated from diarrhoeic piglets for the presence of the enterotoxin gene. Vet Rec 126(8):191–192PubMed
18.
Zurück zum Zitat Baldwin L, Henderson A, Wright M et al (1993) Spontaneous Clostridium perfringens lung abscess unresponsive to penicillin. Anaesth Intensive Care 21(1):117–119PubMed Baldwin L, Henderson A, Wright M et al (1993) Spontaneous Clostridium perfringens lung abscess unresponsive to penicillin. Anaesth Intensive Care 21(1):117–119PubMed
19.
Zurück zum Zitat Unterer S, Busch K, Leipig M et al (2014) Endoscopically visualized lesions, histologic findings, and bacterial invasion in the gastrointestinal mucosa of dogs with acute hemorrhagic diarrhea syndrome. J Vet Intern Med 28(1):52–58CrossRefPubMed Unterer S, Busch K, Leipig M et al (2014) Endoscopically visualized lesions, histologic findings, and bacterial invasion in the gastrointestinal mucosa of dogs with acute hemorrhagic diarrhea syndrome. J Vet Intern Med 28(1):52–58CrossRefPubMed
20.
Zurück zum Zitat Sakurai J, Oshita Y, Fujii Y (1985) Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats. Toxicon 23(6):903–912PubMed Sakurai J, Oshita Y, Fujii Y (1985) Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats. Toxicon 23(6):903–912PubMed
21.
Zurück zum Zitat Sakurai J, Fujii Y, Dezaki K (1984) Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol Immunol 28(1):23–31CrossRefPubMed Sakurai J, Fujii Y, Dezaki K (1984) Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol Immunol 28(1):23–31CrossRefPubMed
22.
Zurück zum Zitat Sakurai J, Fujii Y, Matsuura M (1981) Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol Immunol 25(5):423–432CrossRefPubMed Sakurai J, Fujii Y, Matsuura M (1981) Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol Immunol 25(5):423–432CrossRefPubMed
23.
Zurück zum Zitat Soler-Jover A, Blasi J, Gómez de Aranda I (2004) Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo. J Histochem Cytochem 52(7):931–942CrossRefPubMed Soler-Jover A, Blasi J, Gómez de Aranda I (2004) Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo. J Histochem Cytochem 52(7):931–942CrossRefPubMed
24.
Zurück zum Zitat Nagahama M, Takahashi T, Sakurai J (1990) Effect of prior treatment with Clostridium perfringens epsilon toxin inactivated by various agents on lethal, pressor and contractile activities of the toxin. FEMS Microbiol Lett 60(1–2):59–62CrossRefPubMed Nagahama M, Takahashi T, Sakurai J (1990) Effect of prior treatment with Clostridium perfringens epsilon toxin inactivated by various agents on lethal, pressor and contractile activities of the toxin. FEMS Microbiol Lett 60(1–2):59–62CrossRefPubMed
25.
Zurück zum Zitat Simon TG, Bradley J (2014) Jones A. Massive intravascular hemolysis from Clostridium perfringens septicemia: a review. J Intensive Care Med 29(6):327–333CrossRefPubMed Simon TG, Bradley J (2014) Jones A. Massive intravascular hemolysis from Clostridium perfringens septicemia: a review. J Intensive Care Med 29(6):327–333CrossRefPubMed
26.
Zurück zum Zitat Jemni L, Chatti N, Chakroun M (1988) Clostridium perfringens septicemia. Rev Fr Gynecol Obstet 83(6):407–409PubMed Jemni L, Chatti N, Chakroun M (1988) Clostridium perfringens septicemia. Rev Fr Gynecol Obstet 83(6):407–409PubMed
27.
Zurück zum Zitat Uzal FA, Freedman JC, Shrestha A (2014) Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol 9(3):361–377CrossRefPubMedPubMedCentral Uzal FA, Freedman JC, Shrestha A (2014) Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol 9(3):361–377CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Downes J, Olsvik B, Hiom SJ et al (2000) Bulleidia extructa gen. nov., sp. nov., isolated from the oral cavity. Int J Syst Evol Microbiol 50(3):979–983CrossRefPubMed Downes J, Olsvik B, Hiom SJ et al (2000) Bulleidia extructa gen. nov., sp. nov., isolated from the oral cavity. Int J Syst Evol Microbiol 50(3):979–983CrossRefPubMed
29.
Zurück zum Zitat Kloesel B, Beliveau M, Patel R et al (2013) Bulleidia extructa periprosthetic hip joint infection, United States. Emerg Infect Dis 19(7):1170–1171CrossRefPubMedPubMedCentral Kloesel B, Beliveau M, Patel R et al (2013) Bulleidia extructa periprosthetic hip joint infection, United States. Emerg Infect Dis 19(7):1170–1171CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Reichardt N, Duncan SH, Young P et al (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8(6):1323–1335CrossRefPubMedPubMedCentral Reichardt N, Duncan SH, Young P et al (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8(6):1323–1335CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484CrossRefPubMed Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484CrossRefPubMed
32.
Zurück zum Zitat Schwiertz A, Taras D, Schäfer K et al (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18(1):190–195CrossRef Schwiertz A, Taras D, Schäfer K et al (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18(1):190–195CrossRef
33.
Zurück zum Zitat Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2), e9085CrossRefPubMedPubMedCentral Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2), e9085CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Preidis GA, Ajami NJ, Wong MC et al (2015) Composition and function of the undernourished neonatal mouse intestinal microbiome. J Nutr Biochem 18(5):190–195 Preidis GA, Ajami NJ, Wong MC et al (2015) Composition and function of the undernourished neonatal mouse intestinal microbiome. J Nutr Biochem 18(5):190–195
35.
Zurück zum Zitat Niu Q, Li P, Hao S et al (2015) Dynamic distribution of the gut microbiota and the relationship with apparent crude fiber digestibility and growth stages in pigs. Sci Rep 21(5):9938CrossRef Niu Q, Li P, Hao S et al (2015) Dynamic distribution of the gut microbiota and the relationship with apparent crude fiber digestibility and growth stages in pigs. Sci Rep 21(5):9938CrossRef
Metadaten
Titel
Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China
verfasst von
J. Liu
H. Yang
Z. Yin
X. Jiang
H. Zhong
D. Qiu
F. Zhu
R. Li
Publikationsdatum
17.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2853-z

Weitere Artikel der Ausgabe 4/2017

European Journal of Clinical Microbiology & Infectious Diseases 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.